{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:06:03Z","timestamp":1781629563993,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1R01DK102134-01"],"award-info":[{"award-number":["1R01DK102134-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK117445"],"award-info":[{"award-number":["R01 DK117445"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 MD012765"],"award-info":[{"award-number":["R01 MD012765"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006989","name":"Jackson State University","doi-asserted-by":"publisher","award":["HHSN268201800013I"],"award-info":[{"award-number":["HHSN268201800013I"]}],"id":[{"id":"10.13039\/100006989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.xkme.2021.05.004","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:30:17Z","timestamp":1626327017000},"page":"962-973.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["APOL1, Sickle Cell Trait, and CKD in the Jackson Heart Study"],"prefix":"10.1016","volume":"3","author":[{"given":"Bessie A.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Kestenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2021.05.004_bib1","series-title":"USRDS Annual Data Report: Epidemiology of kidney disease in the United States","year":"2019"},{"issue":"6","key":"10.1016\/j.xkme.2021.05.004_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02599199","article-title":"Patient characteristics related to intensity of weight reduction care in a university medical clinic","volume":"7","author":"Brancati","year":"1992","journal-title":"J\u00a0Gen Intern Med"},{"issue":"23","key":"10.1016\/j.xkme.2021.05.004_bib3","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.1997.03550230045035","article-title":"Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial","volume":"278","author":"Brancati","year":"1997","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.xkme.2021.05.004_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.amjmed.2008.11.021","article-title":"White\/black racial differences in risk of end-stage renal disease and death","volume":"122","author":"Choi","year":"2009","journal-title":"Am J Med"},{"issue":"21","key":"10.1016\/j.xkme.2021.05.004_bib5","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1001\/jama.1992.03490210061036","article-title":"The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors [see comments]","volume":"268","author":"Brancati","year":"1992","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.xkme.2021.05.004_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MNH.0b013e32835012ab","article-title":"APOL1 and kidney disease","volume":"21","author":"Pollak","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5993","key":"10.1016\/j.xkme.2021.05.004_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.xkme.2021.05.004_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.05.017","article-title":"A\u00a0pathophysiology-based approach to the diagnosis and treatment of lupus nephritis","volume":"90","author":"Anders","year":"2016","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.xkme.2021.05.004_bib9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2021.05.004_bib10","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","author":"Grams","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2021.05.004_bib11","first-page":"42","article-title":"Registry shows in-center nocturnal most popular","volume":"22","year":"2008","journal-title":"Nephrol News Issues"},{"issue":"11","key":"10.1016\/j.xkme.2021.05.004_bib12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","article-title":"Genetic variation in APOL1 associates with younger age at hemodialysis initiation","volume":"22","author":"Kanji","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2021.05.004_bib13","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2021.05.004_bib14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.xkme.2021.05.004_bib15","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2021.05.004_bib16","first-page":"603","article-title":"Population genetics of chronic kidney disease: the evolving story of APOL1","volume":"25","author":"Wasser","year":"2012","journal-title":"J\u00a0Nephrol"},{"issue":"20","key":"10.1016\/j.xkme.2021.05.004_bib17","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"issue":"4.suppl 6","key":"10.1016\/j.xkme.2021.05.004_bib18","first-page":"S6-1","article-title":"The Jackson Heart Study: an overview","volume":"15","author":"Taylor","year":"2005","journal-title":"Ethn Dis"},{"issue":"3.suppl 1","key":"10.1016\/j.xkme.2021.05.004_bib19","first-page":"S1-49","article-title":"The Jackson Heart Study of the future","volume":"22","author":"Taylor","year":"2012","journal-title":"Ethn Dis"},{"issue":"4.suppl 6","key":"10.1016\/j.xkme.2021.05.004_bib20","first-page":"S6-18","article-title":"Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description","volume":"15","author":"Fuqua","year":"2005","journal-title":"Ethn Dis"},{"key":"10.1016\/j.xkme.2021.05.004_bib21","first-page":"279","article-title":"Effects of serum creatinine calibration on estimated renal function in African Americans: the Jackson Heart Study","volume":"349","author":"Wang","year":"2015","journal-title":"Am J Med Sci. March"},{"issue":"5","key":"10.1016\/j.xkme.2021.05.004_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.xkme.2021.05.004_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajhg.2012.07.017","article-title":"Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts","volume":"91","author":"Bick","year":"2012","journal-title":"Am J Human Genet"},{"issue":"3","key":"10.1016\/j.xkme.2021.05.004_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000441-200409000-00001","article-title":"Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study","volume":"328","author":"Carpenter","year":"2004","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.xkme.2021.05.004_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.xkme.2021.05.004_bib26","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1681\/ASN.2009050546","article-title":"Rapid decline of kidney function increases cardiovascular risk in the elderly","volume":"20","author":"Shlipak","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.xkme.2021.05.004_bib27","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.xkme.2021.05.004_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2016.02.046","article-title":"Risk factors for rapid kidney function decline among African Americans: the Jackson Heart Study (JHS)","volume":"68","author":"Young","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2021.05.004_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"issue":"23","key":"10.1016\/j.xkme.2021.05.004_bib30","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2021.05.004_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.xkme.2021.05.004_bib32","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2215\/CJN.05220515","article-title":"Examination of potential modifiers of the association of APOL1 alleles with CKD progression","volume":"10","author":"Chen","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2021.05.004_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1681\/ASN.2015020124","article-title":"APOL1 genotype and race differences in incident albuminuria and renal function decline","volume":"27","author":"Peralta","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2021.05.004_bib34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.xkme.2021.05.004_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.semnephrol.2017.07.007","article-title":"The cell biology of APOL1","volume":"37","author":"O'Toole","year":"2017","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2021.05.004_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.semnephrol.2017.07.001","article-title":"Introduction: APOL1-associated kidney disease","volume":"37","author":"Pollak","year":"2017","journal-title":"Semin Nephrol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:23:11Z","timestamp":1762910591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059521001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2590059521001576"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2021.05.004","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1, Sickle Cell Trait, and CKD in the Jackson Heart Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2021.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}